Ronald S. Boshuizen

Sanquin — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index1.3kcitations32works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prion Diseases and Protein Misfolding(12), Alzheimer's disease research and treatments(8), Biosimilars and Bioanalytical Methods(8), Neurological diseases and metabolism(7), Pharmaceutical studies and practices(5)

Publications32 total

Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study
Inflammatory Bowel Diseases·2018· 32 cited
Capillary Blood Microsampling to Determine Serum Biopharmaceutical Concentration: Mitra <sup>®</sup> Microsampler vs Dried Blood Spot
Bioanalysis·2018· 52 cited
Mo1844 - Drug Survival and Immunogenicity after Switching from Remicade ® to Biosimilar Ct-P13 in Inflammatory Bowel Disease Patients: Two Year Follow-Up of a Prospective Observational Cohort Study
Gastroenterology·2018
P490 Drug survival and immunogenicity after switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: Two-year follow-up of a prospective observational cohort study
Journal of Crohn s and Colitis·2018· 3 citedOpen Access
Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease
Digestive Diseases and Sciences·2017· 68 citedOpen Access
Switching From Remicadeâ® to Biosimilar ct-P13 in Inflammatory Bowel Disease Patients: One Year Follow-Up of a Prospective Observational Cohort Study
Gastroenterology·2017
Low level of Rituximab in human breast milk in a patient treated during lactation
Lara D. Veeken·2017· 63 citedOpen Access
P114 Fecal loss of infliximab is underestimated due to proteolysis
Journal of Crohn s and Colitis·2017· 1 citedOpen Access
P663 Switching from Remicade® to biosimilar CT-P13 in inflammatory bowel disease patients: one year follow-up of a prospective observational cohort study
Journal of Crohn s and Colitis·2017· 1 citedOpen Access
Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study
Journal of Crohn s and Colitis·2016· 140 cited
A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2)
mAbs·2014· 24 citedOpen Access
The structural core of prion disease
Data Archiving and Networked Services (DANS)·2010Open Access
Functional Reconstruction of Structurally Complex Epitopes using CLIPS™ Technology
The Open Vaccine Journal·2009· 24 citedOpen Access
Heterologous Stacking of Prion Protein Peptides Reveals Structural Details of Fibrils and Facilitates Complete Inhibition of Fibril Growth
Journal of Biological Chemistry·2009· 6 citedOpen Access
Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide
BMC Neuroscience·2007· 13 citedOpen Access
Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site
Amyloid·2007· 6 cited
Two-rung Model of a Left-handed β-Helix for Prions Explains Species Barrier and Strain Variation in Transmissible Spongiform Encephalopathies
Journal of Molecular Biology·2006· 60 citedOpen Access
Microglial cells kill prion-damaged neurons in vitro by a CD14 dependent process
Journal of Neuroimmunology·2005· 16 cited
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
Glia·2005· 80 cited
Amyloid Associated Proteins in Alzheimers and Prion Disease
Current Drug Targets - CNS & Neurological Disorders·2005· 60 cited
page 1 of 2Next →

Frequent Co-authors

Jan Langeveld(11), Rob H. Meloen(11), Lisa Smits(7), Joost P.H. Drenth(7), Frank Hoentjen(7), Lauranne Derikx(6), Kristian Dalsgaard(5), J. Ignacio Casal(5), Dirk J. de Jong(5), Robert Veerhuis(5), Johannes P. M. Langedijk(5), Sören Kamstrup(4), Piet Eikelenboom(4), W.M.M. Schaaper(4), Steven Williams(4), Michela Morbin(4), Carmen Vela(3), Aura A. J. van Esch(3), Anna Grelack(3), Annick de Vries(3)